Login
Toggle sidebar

Lint: fibrocartilaginous-mesenchymoma

fibrocartilaginous-mesenchymoma
Strong List Colon Position
error

"T1: low signal intensity"

Line 63:8 · When enboldening an intro, the colon should not be bold. '<strong>T1:</strong> low'

"T2: high signal intensity"

Line 64:8 · When enboldening an intro, the colon should not be bold. '<strong>T2:</strong> high'

"T1 C+ (Gd): strong enhancement"

Line 65:8 · When enboldening an intro, the colon should not be bold. '<strong>T1 C+ (Gd): </strong>strong'
Strong
warning

"Fibrocartilaginous mesenchymomas have been most commonly found in the following locations 1-6:"

Line 23:108 · Generally, don't use bold in text: '<strong>:</strong>'
Emphasis
warning

"Fibrocartilaginous mesenchymomas lack mutations in GNAS, IDH1 and IDH2 as well as amplifications of MDM2 1,6."

Line 52:55 · Italics should be used only in exceptional circumstances: '<em>GNAS</em>,<em> IDH1</em> and <em>IDH2</em> as well as amplifications of <em>MDM2</em>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Pathology"

Line 18:1 · "Pathology" should be H1, not H2.

"Aetiology"

Line 20:1 · "Aetiology" is under the wrong parent heading (found under "Clinical presentation").

"Location"

Line 22:1 · "Location" is under the wrong parent heading (found under "Clinical presentation").

"Macroscopic appearance"

Line 31:1 · "Macroscopic appearance" is under the wrong parent heading (found under "Clinical presentation").

"Microscopic appearance"

Line 33:1 · "Microscopic appearance" is under the wrong parent heading (found under "Clinical presentation").

"Immunophenotype"

Line 49:1 · "Immunophenotype" is under the wrong parent heading (found under "Clinical presentation").

"Genetics"

Line 51:1 · "Genetics" is under the wrong parent heading (found under "Clinical presentation").
Oxford Comma
suggestion

"Fibrocartilaginous mesenchymomas are very rare tumours. They occur in children, adolescents and young adults up to the third decade 1-3. The male gender is slightly more frequently affected 1."

Line 5:74 · Use the Oxford comma in 'children, adolescents and young'.

"Fibrocartilaginous mesenchymomas lack mutations in GNAS, IDH1 and IDH2 as well as amplifications of MDM2 1,6."

Line 52:59 · Use the Oxford comma in 'GNAS, IDH1 and IDH2'.
Biographical Lifespan
suggestion

"History and etymology"

Line 78:1 · A bold element in the History and etymology section should be a person; it would be useful to have their lifespan details: '<h4>History and etymology</h4> <p>The entity was first described by the American pathologist <strong>David Carl Dahlin</strong> '
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0